Clinical trial
Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or…
NCT00094848 · Human Genome Sciences Inc., Industry · Completed
Key facts
| NCT number | NCT00094848 |
|---|---|
| Title | Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) |
| Official title | A Multi-Center, Open-Label, Dose-Escalation Study to Evaluate the Safety, Efficacy, and Exposure to TRM-1 (Fully Human Monoclonal Antibody to the TRAIL-R1) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma |
| Lead sponsor | Human Genome Sciences Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin |
| Intervention type | Drug |
| Interventions | TRAIL-R1 mAb (TRM-1, HGS-ETR1) |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Oct 27, 2004 |
| Last update posted | Aug 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: